The U.S. 2018 Farm Bill may have inadvertently legalized the chemical conversion of hemp-derived cannabidiol (CBD) and other phytocannabinoids into intoxicating minor cannabinoids like delta-8 tetrahydrocannabinol (∆8-THC), leading to a booming industry without adequate regulatory oversight. Our stance at D4DPR is that all intoxicating cannabinoids should be subject to a regulatory framework to ensure public safety.
1/2025: This position paper has been updated and retitled "Recommendations for Regulating Semi-Synthetic Intoxicating Cannabinoids Derived from Hemp."
Bryon Adinoff, MD is an addiction psychiatrist, neuroscientist, academician, and advocate. He was appointed Clinical Professor at the University of Colorado School of Medicine following his retirement as Distinguished Professor of Alcohol and Drug Abuse Research in the Department of Psychiatry at the University of Texas Southwestern Medical Center and as a psychiatrist for 30 years with the Department of Veterans Affairs. He has published over 200 papers and book chapters on the neurobiology and treatment of addiction and is Editor-in-Chief of The American Journal of Drug and Alcohol Abuse. In his semi-retired status, he has evolved from focusing on the consequences of substance use itself to the consequences of drug prohibition. His commitment to the goals of D4DPR arises from his desire to ensure that the devastating effects of the global drug war are replaced by a science-based, compassionate, and just system that protects both the individual and society.
.svg)
